3 nominees · 5 ballot items.
Election of three Class III directors; ratification of PricewaterhouseCoopers LLP as independent auditor; advisory approval of named executive officers’ compensation (say-on-pay); approval of amendments to the Company’s certificate of incorporation to eliminate Class B/C stock and add officer exculpation (Charter Amendment); and approval of the Company’s 2026 Employee Stock Purchase Plan (ESPP).
Elect three Class III directors to serve until the 2029 annual meeting.
Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory vote to approve, on a non-binding basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement.
This non-binding advisory proposal asks stockholders to approve the company’s named executive officer (NEO) pay as disclosed in the proxy statement. Management seeks approval to validate its pay philosophy and to continue its current compensation approach, which emphasizes equity (RSUs and PSUs) and performance-based annual cash incentives tied to company metrics (volume, gross revenue less network fees, and adjusted EBITDA). The proxy describes that roughly 91–92% of CEO and NEO target compensation is equity-based, with most RSUs vesting over three years and additional PSUs tied to adjusted free cash flow targets, reflecting a strong pay-for-performance design intended to align executive interests with long-term shareholder value. The Board frames the advisory vote as a mechanism for stockholder engagement and notes it will consider the vote outcome in future compensation decisions; the vote is non-binding and does not alter contractual pay arrangements. The company also discloses governance practices intended to mitigate excessive risk, including consultant review, equity vesting schedules, clawback policy, and stock ownership guidelines. For sophisticated analysis: the proposal is an information signal about stockholder sentiment on pay mix, magnitude and link to performance — high equity weighting increases alignment but also concentrates upside and dilution; the Board’s recent compensation actions (one-time awards, special retention grants and significant CEO/COO/CFO equity) and transitions (CEO change in 2025) create context for elevated pay levels, making the advisory result an important gauge for future committee behavior. While management emphasizes strong performance vs targets and high say-on-pay support historically, activists or large holders could critique the scale or timing of special awards; nonetheless, a FOR vote supports continuity in the Board’s compensation design and its rationale for retention and long-term alignment.
Approve amendments to the Company’s certificate of incorporation to (i) eliminate authorization and references to Class B and Class C common stock (Simplification Amendment) and (ii) provide for officer exculpation to the fullest extent permitted by Delaware law (Officer Exculpation Amendment).
This proposal asks stockholders to approve a two-part charter amendment: (1) a technical and structural Simplification Amendment that removes the authorization and references to the Company’s former Class B and Class C shares following the Simplification Transactions/Up-C Collapse, and (2) an Officer Exculpation Amendment to add officer exculpation to the extent permitted by the amended Section 102(b)(7) of the Delaware General Corporation Law. Management’s rationale is operational and governance-oriented: the Simplification Amendment formally collapses the multi-class legacy charter provisions that are now obsolete after the February 2026 simplification transactions (including Rook’s exchange/redemption and assignment/waiver of TRA rights), reducing potential shareholder confusion and aligning authorized capital with current needs. The Officer Exculpation Amendment is justified by the Board as a recruitment and retention tool to limit officers’ monetary exposure for duty-of-care claims in derivative or stockholder suits (while preserving liability for duty-of-loyalty, bad faith, and knowing law violations), and to align officer protections with those already afforded to directors. For a sophisticated assessment: approval reduces structural complexity and removes lingering ‘up‑C’ remnants that could impede capital management and clarity; the transaction context (the Simplification Transactions and assignment/waiver of TRA rights, and the founder/major-holder dynamics) materially reduces the need for legacy governance provisions. The exculpation element is more controversial: while it can lower personal litigation risk and thereby broaden the officer candidate pool and reduce defense costs, it narrows shareholder remedies for certain care-related claims and could be viewed by some investors as reducing accountability — however, under DGCL Amended 102(b)(7) exculpation remains subject to statutory limits (no exculpation for duty of loyalty, bad faith, intentional misconduct, knowing law violations, or personal benefit transactions). The Board emphasizes that exculpation does not affect derivative claims brought in the Company’s name or claims for loyalty/bad-faith conduct, but stockholders should weigh the benefit of simpler capital structure and managerial recruitment/retention against the incremental governance protection afforded to officers. Overall, the amendment is management-driven, tied to completed corporate transactions, and recommended by the Board as aligning charter language with the Company’s post‑simplification structure and governance objectives.
Approve the Company’s 2026 Employee Stock Purchase Plan authorizing 1,500,000 shares (with annual replenishments equal to 1% of Class A outstanding each year through 2036) to allow eligible employees to purchase Class A common stock at a discount.
This proposal asks stockholders to approve a new Employee Stock Purchase Plan to authorize 1,500,000 shares for issuance (with an annual automatic increase mechanism equal to 1% of outstanding Class A shares each year through 2036, subject to a Board-set lower amount), and to allow eligible employees to buy shares through payroll deductions at a discount (minimum 85% of lesser of offering start or purchase date price) under both a Section 423-qualified component and a Non-Section 423 component for non-U.S. participants. Management frames the ESPP as a broad-based retention and incentive program that builds employee ownership, aligns employee interests with stockholders, and enhances recruitment. The Board notes the initial reserve is roughly 2% of outstanding Class A stock as of the record date and considered the size reasonable; the Administrator (the Compensation Committee) controls offering design, eligibility, purchase limits (default 750 shares per offering or $25,000 limit under Section 423), and anti‑dilution adjustments. For sophisticated analysis: approval would create dilution risk (initial reserve and future annual increases) but is a standard corporate practice to support recruiting, retention and employee alignment; the two-component design permits tax-qualified participation for U.S. employees while allowing flexibility for non-U.S. jurisdictions. Key governance points include plan administration by the Compensation Committee, limitations on aggregate issuance (cap at 15,000,000 shares overall under the ESPP), and standard anti‑dilution and adjustment protections for corporate events. The Board concludes the ESPP’s benefits in employee motivation and alignment justify the modest dilution and recommends stockholder approval.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | DARLINGTON PARTNERS CAPITAL MANAGEMENT, LP | 8.29% | 6,576,509 | $288M |
| 2 | Durable Capital Partners LP | 7.77% | 6,165,793 | $270M |
| 3 | WASATCH ADVISORS LP | 5.30% | 4,206,244 | $184M |
| 4 | BlackRock, Inc. | 4.98% | 3,954,443 | $173M |
| 5 | Ensign Peak Advisors, Inc | 3.92% | 3,106,441 | $136M |
| 6 | Neuberger Berman Group LLC | 3.18% | 2,519,905 | $110M |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.88% | 2,286,184 | $100M |
| 8 | UBS Group AG | 2.64% | 2,097,113 | $92M |
| 9 | STATE STREET CORP | 2.61% | 2,066,962 | $90M |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.55% | 2,023,932 | $89M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.